Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder in 2011
24 hours) reduces the expression of GPX4 protein
methicillin-resistant Staphylococcus aureus (MRSA) strain with a minimum inhibitory concentration (MIC) of 0
InChi: InChI=1S/C13H15N5
2-Thiophenecarbonitrile
7-Chlorokynurenic acid sodium salt Size:Contact [email protected] for quotation Vilazodone was approved by the7 Chlorokynurenic acid sodium salt (7 CKA sodium salt) is a potent and selective antagonist of the glycine B coagonist site of the N methyl D aspartate (NMDA) receptor (IC50=0. 56 M). 7 Chlorokynurenic acid sodium salt is also a potent inhibitor of the reuptake of glutamate into synaptic vesicles with a Ki of 0. 59 M. 7 Chlorokynurenic acid sodium salt has potent antinociceptive actions after neuraxial delivery. Product information CAS Number: 1263094
US$ 20.00
US$ 84.99
US$ 112.50
US$ 125.00